Dosage Card
In 2008 the EANM published the first version of the paediatric dosage card. In 2011, the North American consensus guidelines recommended a set of administered activities for paediatric nuclear medicine. During the EANM Congress in 2012, a working group of the EANM and the SNMMI met to study the possibilities to harmonise these guidelines. The purpose of this publication was to identify differences between these guidelines and suggest changes in both to achieve a level of harmonisation. In August 2016, the last update of the EANM Paediatric Dosage Card was issued.
Dosage Card
This card is based upon the publication by Jacobs F, Thierens H, Piepsz A, Bacher K, Van de Wiele C, Ham H, Dierckx RA. Optimized tracer-dependent dosage cards to obtain weight independent effective doses. Eur J Nucl Med Mol Imaging. 2005 May; 32(5):581-8.
M. Lassmann, S.T.Treves. Pediatric Radiopharmaceutical Administration: Harmonization of the 2007 EANM Paediatric Dosage Card (Version 1.5.2008) and the 2010 North America Consensus guideline, Eur J Nucl Med Mol Imaging. 2014, DOI: 10.1007/s00259-014-2731-9.
Lassmann M, Biassoni L, Monsieurs M, Franzius C; EANM Dosimetry and Paediatrics Committees. The new EANM paediatric dosage card: additional notes with respect to F-18. Eur J Nucl Med Mol Imaging. 2008 Sep;35(9):1666-8. DOI: 10.1007/s00259-008-0799-9. Epub 2008 Jun 24. Erratum in: Eur J Nucl Med Mol Imaging. 2008 Nov;35(11):2141
This card summarises the views of the Paediatric and Dosimetry Committees of the EANM and reflects recommendations for which the EANM cannot be held responsible. The dosage recommendations should be taken in the context of “good practice” of nuclear medicine and do not substitute for national and international legal or regulatory provisions.
Download the Dosage card as a PDF
PedDose App
In addition to the dosage card, the PedDose App was developed and downloaded over 2,500 times on Google Play; users rated it with 4.1 out of 5 stars.
It is currently undergoing an update and will be available again soon. Stay tuned!